Nuevocor draws $45M series B for gene therapy in rare heart disease

May 7, 2025

Nuevocor Pte. Ltd. has closed a $45 million series B, enabling it to move lead gene therapy NVC-001 into the clinic in the treatment of an inherited form of cardiomyopathy.

BioWorld Science Clinical Financings Science Cardiovascular Gene therapy Series B Asia-Pacific Europe U.S.

Today's news in brief

BioWorld

BioWorld briefs for May 13, 2026.

Alzheimer’s, beyond the brain

BioWorld

Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 12, 2026

Hantavirus zoonotic spillover illustration

First cruise ship hantavirus genome points to zoonotic spillover

BioWorld

The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...

Makary out at the FDA

BioWorld

U.S. President Donald Trump ended days of rumors and speculation when he confirmed May 12 that Marty Makary is resigning as FDA commissioner. Speaking with...